US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INVESCO BIOTECHNOLOGY & GENOME ETF

96.90

+2.642.80%

Post-market: 96.77-0.1261-0.13%19:30 EDT

Volume:3K

Turnover:284.08K

Market Cap:423.44M

PE:54.03

High:96.90

Open:94.43

Low:94.43

Close:94.25

52wk High:98.82

52wk Low:70.01

Shares:4.37M

Float Shares:4.37M

Volume Ratio:0.23

T/O Rate:0.07%

Dividend:1.33

Dividend Rate:1.37%

EPS(TTM):1.79

EPS(LYR):18.65

ROE:24.76%

ROA:0.08%

PB:1.71

PE(LYR):5.19

Loading ...

Overview Company News Filings

11% Undervalued? Vertex Pharmaceuticals (VRTX) Following New ALYFTREK Data

Simply Wall St.

Amgen Inc. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains

U.S. Stocks on the MOVE -VF Corp, Biogen, AbbVie

Vertex Pharmaceuticals to present data on Alyftrek at NACFC

Vertex Says Interim Alyftrek Study Data Show Some CF Children Ages 2-5 Regain Pancreatic Function

Vertex and Moderna Advance CF mRNA Therapy: What VX-522 Trial Completion Means for Investors

UBS Lifts Biogen PT on Late-Stage Pipeline Catalysts; Shares Rise

Royalty Pharma to Report Q3 2026 Results, Host Conference Call and Webcast

Royalty Pharma to Announce Third Quarter 2026 Financial Results on November 4, 2026

THOMSON REUTERS

Sino Biopharmaceutical Stock Falls 1.4% in Hong Kong

Linical Wins $20 Million U.S. Biotech Order as FDA Environment Normalizes

Amgen (AMGN) In Focus As MariTide Buzz Tests Whether The Stock Is Fully Valued

Simply Wall St.

Vertex to Raise Up to C$7 Million in Subordinated Loan with Attached Warrants

Press Release: Vertex Resource GROUP LTD. Announces Subordinated TERM LOAN of up to C$7,000,000

Biogen Inc. Stock Underperforms Thursday When Compared to Competitors

Amgen’s Monthly Diabetes Shot Takes Aim at Semaglutide in New Phase 3 Trial

Dow's Nearly 150-Point Fall Led by Losses for Shares of Amgen, Johnson & Johnson

Amgen Stock Forecast: Pipeline Wins Strengthen Growth Story as MariTide Phase 3 Advances

Alnylam Pharmaceuticals (ALNY) Is Under Securities Fraud Investigation

Simply Wall St.

Biogen : RBC Cuts Target Price to $256 from $260

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/PBE/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PBE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","market":"US","secType":"STK","nameCN":"INVESCO BIOTECHNOLOGY & GENOME ETF","latestPrice":96.8962,"timestamp":1791576000000,"preClose":94.2541,"halted":0,"volume":2945,"hourTrading":{"tag":"盘后","latestPrice":96.7701,"preClose":96.8962,"latestTime":"19:30 EDT","volume":7,"amount":677.6832,"timestamp":1791588606237,"change":-0.1261,"changeRate":-0.001301,"amplitude":0},"delay":0,"changeRate":0.028031671831782377,"floatShares":4370000,"shares":4370000,"eps":1.793292,"marketStatus":"Market Closed","change":2.6421,"latestTime":"10-09 16:00:00 EDT","open":94.43,"high":96.8962,"low":94.43,"amount":284075.90745,"amplitude":0.026165,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":1.793292,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":94.2541,"sharesOutstanding":3180000,"nav":94.23351,"aum":409915768.5,"dividendRate":0.013716,"bidAskSpread":0.002189,"postHourTrading":{"tag":"盘后","latestPrice":96.7701,"preClose":96.8962,"latestTime":"19:30 EDT","volume":7,"amount":677.6832,"timestamp":1791588606237,"change":-0.1261,"changeRate":-0.001301,"amplitude":0},"volumeRatio":0.227009940754514,"impliedVol":0.1917,"impliedVolPercentile":0.5498},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","floatShares":4370000,"roa":"0.08%","roe":"24.76%","lyrEps":18.654418,"volumeRatio":0.227009940754514,"shares":4370000,"dividePrice":1.329,"high":96.8962,"amplitude":0.026165,"preClose":94.2541,"low":94.43,"week52Low":70.01,"pbRate":"1.71","psRate":"246.66","week52High":98.82,"institutionHeld":0.2552,"latestPrice":96.8962,"eps":1.793292,"divideRate":0.013716,"volume":2945,"delay":0,"ttmEps":1.793292,"open":94.43,"prevYearClose":82.15,"prevWeekClose":95.07,"prevMonthClose":97.2888,"prevQuarterClose":97.2888,"fiveDayClose":95.07,"twentyDayClose":92.91,"sixtyDayClose":91.0787},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBE\",params:#limit:5,,,undefined,":[{"date":"2026-09-21","symbol":"PBE","amount":0.01867,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-21","defaultRemindTime":1789997400000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-25","payableDate":"2026-09-21","currency":"USD","dateTimestamp":1789963200000,"payDate":"2026-09-25"},{"date":"2026-06-22","symbol":"PBE","amount":0.81061,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"PBE","amount":0.08244,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"PBE","amount":0.41972,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"PBE","amount":0.23409,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBE\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.1208,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-31","value":0.05552,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-30","value":0.21532,"currency":"USD"},{"executeDate":"2018-09-24","recordDate":"2018-09-25","paymentDate":"2018-09-28","value":0.00207,"currency":"USD"},{"executeDate":"2020-03-23","recordDate":"2020-03-24","paymentDate":"2020-03-31","value":0.02898,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBE\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2674889959","title":"11% Undervalued? Vertex Pharmaceuticals (VRTX) Following New ALYFTREK Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2674889959","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674889959?lang=en_us&edition=fundamental","pubTime":"2026-10-10 15:30","pubTimestamp":1791617441,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals (VRTX) just put fresh clinical data for ALYFTREK in front of cystic fibrosis specialists at the North American Cystic Fibrosis Conference, highlighting early pancreatic function recovery in some very young children.\nVertex Pharmaceuticals’ recent ALYFTREK data arrives while the share price has climbed 12.82% year to date and the 1-year total shareholder return of 25.08% points to solid momentum, with a 5.09% 90-day share price return suggesting that investors are...","market":"us","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/36235-card/1788967613256","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/36235-card/1788967613256"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vrtx/vertex-pharmaceuticals/news/11-undervalued-vertex-pharmaceuticals-vrtx-following-new-aly","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vrtx/vertex-pharmaceuticals/news/11-undervalued-vertex-pharmaceuticals-vrtx-following-new-aly","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0889565916.HKD","LU1585245621.USD","IDNA","IE00B19Z9Z06.USD","LU2362541513.USD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","IBB","BK4588","IE00BZ9MQY76.HKD","LU1093756168.USD","LU0823416689.USD","LU1069344957.HKD","LU0058720904.USD","LU2089984988.USD","LU2462157665.USD","VERX","VRTX","LU2456880835.USD","LU1093756325.SGD","LU2362541273.HKD","LU0757428866.USD","GNMX","IE0009355771.USD","BK4023","IE00B894F039.SGD","BBH","LU0289739699.SGD","IE00B19Z9P08.USD","BK4567","LU0109394709.USD","LU1559883803.SGD","BK4139","LU1674673428.USD","BIB","IBBQ","TBXU","LU2236285917.USD","LU2417539215.USD","BK4532","LU1778281490.HKD","PBE","LU0234570918.USD","LU0061475181.USD","LU1674673691.USD","IE0002270589.USD","LU0566484027.USD","IE00BJT1NW94.SGD","BK4585","LU0256863811.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674861455","title":"Amgen Inc. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2674861455","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674861455?lang=en_us&edition=fundamental","pubTime":"2026-10-10 04:34","pubTimestamp":1791578040,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily GainsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  advanced 1.82% to $414.87 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.59% to 7,811.54 and the Dow Jones Industrial Average  rising 0.83% to 51,654.95.Amgen Inc. closed 7.19% short of its 52-week high of $447.03, which the company reached on August 25th.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson  rose 1.93% to $261.44, Pfizer Inc.  rose 1.65% to $28.28, and AbbVie Inc.  rose 1.49% to $276.47.Trading volume  remained 824,175 below its 50-day average volume of 2.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 9, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","IE00BJJMRZ35.SGD","LU0058720904.USD","LU1983299246.USD","PJP","BK4566","IE00BJT1NW94.SGD","BK4139","IE00B2B36J28.USD","PBE","LU0122379950.USD","LU0889565916.HKD","LU1571399168.USD","LU2112291526.USD","IE0009355771.USD","IBBQ","BIB","BK4585","IE00BFTCPJ56.SGD","BK4534","LU2468319806.SGD","TBXU","BK4588","LU0109394709.USD","IE00B4R5TH58.HKD","BK4581","LU0289739699.SGD","LU0868494617.USD","LU2089984988.USD","LU2242646821.SGD","LU1023059063.AUD","IE0002141913.USD","SG9999001440.SGD","LU2242652126.USD","BBH","LU1057294990.SGD","BK4599","04332","BK4533","AMGN","LU0320765992.SGD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674505866","title":"U.S. Stocks on the MOVE -VF Corp, Biogen, AbbVie","url":"https://stock-news.laohu8.com/highlight/detail?id=2674505866","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674505866?lang=en_us&edition=fundamental","pubTime":"2026-10-10 01:44","pubTimestamp":1791567849,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE -VF Corp, Biogen, AbbVieOct 9 (Reuters)-US stock indexes advanced broadly on Friday and were on pace to clock weekly gains, as investors looked forward to the earnings sea","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261009:nL6N45V0KK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0310799852.SGD","RXL","LU1670711123.USD","LU2129689431.USD","ABBV","LU1670628061.USD","IE00B19Z9P08.USD","LU0057025933.USD","BK4504","LU0708994859.HKD","BK4532","BK4533","LU1934455277.USD","PJP","XLV","VFC","LU0511384066.AUD","LU0211328371.USD","IE00BDGV0183.EUR","BK4588","LU1670711040.USD","LU2468319806.SGD","LU1929549753.HKD","IE0000B7K699.USD","LU2089984988.USD","LU1244550577.SGD","LU0320765992.SGD","FHLC","LU2023251221.USD","IE00B19Z9Z06.USD","LU0965509101.SGD","IE0009355771.USD","LU0069063385.USD","LU0203345920.USD","LU2347655073.USD","LU1244550221.USD","IE00B19Z3581.USD","LU2237443465.HKD","LU0985320562.USD","PPH","SG9999015945.SGD","SG9999015978.USD","LU2347655156.SGD","IE00B894F039.SGD","LU1093756168.USD","LU1934455194.USD","SG9999001440.SGD","LU0726765562.USD","IE00BJT1NW94.SGD","LU2125909593.SGD","LU1162221912.USD","IYH","LU1291159041.SGD","IE00BVYPNW00.USD","LU0912757837.SGD","LU1093756325.SGD","BK4559","LU0889565916.HKD","BMED","IE00B4R5TH58.HKD","IE00BLSP4452.SGD","LU0472753341.HKD","BK4566","LU0689472784.USD","LU1023059063.AUD","LU2089284900.SGD","LU2089283258.USD","IE00B2B36J28.USD","LU1989771016.USD","LU2433249047.HKD","LU1670627923.USD","IE0002141913.USD","MEDX","LU0158827948.USD","LU0417517546.SGD","FTXH","LU0965509283.SGD","LU1548497426.USD","LU1003077747.HKD","SG9999003800.SGD","BK4139","LU0942090050.USD","LU0661504455.SGD","LU0058720904.USD","LU1057294990.SGD","BK4585","BK4550","LU1236620834.HKD","LU0795875086.SGD","IE000F7OJYX1.SGD","IE000WAW04H5.SGD","LU2237443622.USD","IE00BJJMRZ35.SGD","IE00B3PB1722.GBP","LU0868494708.USD","LU1720051017.SGD","LU0943347566.SGD","LU1732799900.SGD","SG9999015986.USD","LU0320765646.SGD","LU0029864427.USD","VHT","LU2112291526.USD","LU1430594728.SGD","LU0820561909.HKD","IE000MB6IJN5.SGD","LU1989772923.USD","LU0456855351.SGD","LU0128525929.USD","LU1732800096.USD","LU0553294199.USD","LU2133065610.SGD","LU0882574055.USD","LU1267930490.SGD","LU0965508806.USD","LU1496350502.SGD","LU0234572021.USD","LU0198837287.USD","LU0114720955.EUR","LU0211327993.USD","AGNG","LU0868494617.USD","LU0965509010.AUD","IE000SO60NU8.SGD","BK4581","LU1244550494.USD","SG9999015952.SGD","LU1720051108.HKD","LU1236620750.USD","LU0795875169.SGD","LU1061106388.HKD","IE00BGHQF631.EUR","LU0859254822.USD","LU0689626769.HKD","LU1551013425.SGD","LU1037948541.HKD","LU0820561818.USD","LU0395794307.EUR","LU1496350171.SGD","LU1983299246.USD","LU1074936037.SGD","LU2129689605.HKD","LU2125909247.SGD","LU2237443895.HKD","LU0122379950.USD","LU0124676726.USD","LU0432979614.USD","LU1934455863.HKD","LU1670710588.SGD","LU0949170772.SGD","LU1551013342.USD","LU0861579265.USD","IE00BVYPNV92.GBP","LU2087621335.USD","BK4202","LU0289739343.SGD","IE00BLSP4239.USD","IE0002270589.USD","IE00B42XCP33.USD","PBE","BIIB","LU0289739699.SGD","LU0203347892.USD","LU1267930573.SGD","IE00B19Z3B42.SGD","LU1670710661.SGD","LU2357305700.SGD","GLAM","LU0823416689.USD","LU2237443382.USD","IE0004445239.USD","JDOC","LU0098860793.USD","LU2237443978.SGD","BK4534","IE00BFTCPJ56.SGD","TRUH","IE00BBT3K403.USD","LU0545039389.USD","LU2129689514.USD","LU1923622614.USD","LU1037948897.HKD","LU2237443549.SGD","IE000BZT7R73.USD","SG9999011175.SGD","LU0738911758.USD","LU1989772840.SGD","IE00BSNM7G36.USD","LU1839511570.USD","IXJ","LU0310800379.SGD","LU0256863902.USD","LU0109394709.USD","LU1718418525.SGD","LU0170899867.USD","LU0289961442.SGD","LU0234570918.USD","LU0256863811.USD","IE00BN8TJ469.HKD","LU2357627491.SGD","LU1585245621.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674866511","title":"Vertex Pharmaceuticals to present data on Alyftrek at NACFC","url":"https://stock-news.laohu8.com/highlight/detail?id=2674866511","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674866511?lang=en_us&edition=fundamental","pubTime":"2026-10-10 01:20","pubTimestamp":1791566419,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals (VRTX) announced new interim data from the ALYFTREK 2 to 5 years old open-label extension study, highlighting recovery of ex...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-to-present-data-on-alyftrek-at-nacfc-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-to-present-data-on-alyftrek-at-nacfc-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1585245621.USD","IDNA","LU2237438978.USD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","IBB","BK4588","IE00BZ9MQY76.HKD","LU2089984988.USD","SG9999001176.USD","VERX","VRTX","LU1093756325.SGD","SG9999013999.USD","LU0320765992.SGD","LU2362541273.HKD","BK4533","SG9999001176.SGD","GNMX","IE0009355771.USD","BK4023","LU0417517546.SGD","IE00B894F039.SGD","BBH","LU0289739699.SGD","IE00B19Z9P08.USD","LU1035775433.USD","BK4567","LU0109394709.USD","LU2324357040.USD","BK4139","LU1674673428.USD","BIB","IBBQ","TBXU","LU2236285917.USD","IE00B19Z3B42.SGD","BK4532","IE00B2B36J28.USD","LU1778281490.HKD","LU2468319806.SGD","PBE","IE00B4R5TH58.HKD","LU0234570918.USD","LU0061475181.USD","LU1674673691.USD","LU0432979614.USD","IE0002270589.USD","IE00BJT1NW94.SGD","LU0256863811.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674865094","title":"Vertex Says Interim Alyftrek Study Data Show Some CF Children Ages 2-5 Regain Pancreatic Function","url":"https://stock-news.laohu8.com/highlight/detail?id=2674865094","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674865094?lang=en_us&edition=fundamental","pubTime":"2026-10-10 01:15","pubTimestamp":1791566131,"startTime":"0","endTime":"0","summary":"Vertex says interim ALYFTREK study data show some CF children ages 2-5 regain pancreatic functionVertex flagged interim trial data on ALYFTREK showing some cystic fibrosis children ages 2 to 5 regaine","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261009:nNDL2tJqZ6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0079474960.USD","LU2237438978.USD","IE00B19Z3B42.SGD","LU0109394709.USD","LU0289739699.SGD","IE0002270589.USD","LU0320765992.SGD","LU0234570918.USD","LU2362541273.HKD","TBXU","GNMX","IDNA","BK4533","LU0823416689.USD","IE00B19Z3581.USD","LU0417517546.SGD","LU2417539215.USD","LU0889565916.HKD","BK4532","LU0058720904.USD","LU1674673691.USD","SG9999013999.USD","IE00B2B36J28.USD","IE00BZ9MQY76.HKD","LU1674673428.USD","IE00B19Z9Z06.USD","LU2362541513.USD","IE0002141913.USD","LU2324357040.USD","BK4139","IE00B894F039.SGD","SG9999001176.SGD","IE00B4R5TH58.HKD","VRTX","PBE","BBH","LU2468319806.SGD","BIB","BK4585","LU1069344957.HKD","LU1778281490.HKD","IBBQ","LU1093756325.SGD","LU2089984988.USD","IE00BJT1NW94.SGD","IBB","LU0432979614.USD","LU2462157665.USD","LU1093756168.USD","LU0061475181.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674902865","title":"Vertex and Moderna Advance CF mRNA Therapy: What VX-522 Trial Completion Means for Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2674902865","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674902865?lang=en_us&edition=fundamental","pubTime":"2026-10-10 00:30","pubTimestamp":1791563440,"startTime":"0","endTime":"0","summary":"Moderna ($MRNA), Vertex Pharmaceuticals Inc. ($VRTX) announced an update on their ongoing clinical study. The Phase 1/2 study titled “A Phase 1/2 D...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-and-moderna-advance-cf-mrna-therapy-what-vx-522-trial-completion-means-for-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-and-moderna-advance-cf-mrna-therapy-what-vx-522-trial-completion-means-for-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2324357040.USD","BK4501","IE0009355771.USD","SG9999001176.SGD","LU2237438978.USD","PBE","LU2362541513.USD","IE0002270589.USD","LU1585245621.USD","IE00B894F039.SGD","MRNY","IE00B4R5TH58.HKD","LU0566484027.USD","ISBC","LU1069344957.HKD","IE00BJJMRZ35.SGD","MRNA","IBBQ","IE00BJT1NW94.SGD","LU0061475181.USD","VERX","LU2362541273.HKD","WDNA","LU2362540622.SGD","BBH","BK4588","GNMX","LU1093756168.USD","VRTX","IE00B2B36J28.USD","LU0289739699.SGD","LU0889565916.HKD","IE00B19Z9P08.USD","BK4551","LGHT","BK4585","MRNX","GNOM","LU0320765992.SGD","BIB","TBXU","IE00BFTCPJ56.SGD","BK4139","IDNA","IBB","BK4567","LU0757428866.USD","LU1778281490.HKD","BK4548","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674863711","title":"UBS Lifts Biogen PT on Late-Stage Pipeline Catalysts; Shares Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2674863711","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674863711?lang=en_us&edition=fundamental","pubTime":"2026-10-10 00:05","pubTimestamp":1791561945,"startTime":"0","endTime":"0","summary":"BUZZ-UBS lifts Biogen PT on late-stage pipeline catalysts; shares rise** Shares of drugmaker BiogenBIIB.Orise 2.4% to $223.71** UBS raises PT to $270 from $240, reiterates \"buy\"** Sees Q3 revenue of $2.69 billion and EPS of $2.11, both slightly above consensus** Expects Alzheimer's drug Leqembi Q3 sales of $200 million, in line with consensus, and says the recently launched subcutaneous formulation could become a meaningful growth driver from 2027** Says Biogen is more optimistic on eye disease drug, Syfovre, than at the time of theApellis acquisitionand is refining its launch strategy** Flags late-stage data for lupus drug litifilimab later this year and cutaneous lupus data in H1 2027 as key catalysts** Also sees upside from late-stage data for kidney-disease drug, felzartamab, due in H1 2027 and potential positive read-through from Eli Lilly'sLLY.Npre-symptomatic Alzheimer's trial** Including session moves, stock up 26.3% YTD","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261009:nL4N45V166:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","LU0234570918.USD","BMED","BK4532","BK4585","IE00B894F039.SGD","LU0889565916.HKD","IE00B19Z9P08.USD","BIIB","BK4139","IE00B19Z9Z06.USD","PBE","LU0320765992.SGD","LU0109394709.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674541208","title":"Royalty Pharma to Report Q3 2026 Results, Host Conference Call and Webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2674541208","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674541208?lang=en_us&edition=fundamental","pubTime":"2026-10-09 20:50","pubTimestamp":1791550212,"startTime":"0","endTime":"0","summary":"Royalty Pharma to report Q3 2026 results, host conference call and webcastRoyalty Pharma schedules third-quarter 2026 results for Nov. 4, 2026, before the U.S. market open.Conference call, webcast set","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261009:nNDL3Z848f:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","IE00B64PRP62.GBP","IE00BQXX3D17.EUR","IE00BQXX3F31.USD","IE00BN0W2V16.EUR","BK4585","BK4007","IHE","RPRX","PBE","IE00BGHQF748.EUR","IE00BQXX3C00.GBP","BK4588","IE00B3QW5Z07.USD","LU2210150020.SGD","IE00BKPKM429.USD","SG9999014039.USD","LU0314104364.USD","SG9999014005.SGD","SG9999014021.USD","BCDF","LU2210149790.SGD","LU2095319765.USD","NDAQ","SG9999014013.SGD","IE00BN0W2W23.USD","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674854123","title":"Royalty Pharma to Announce Third Quarter 2026 Financial Results on November 4, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2674854123","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674854123?lang=en_us&edition=fundamental","pubTime":"2026-10-09 20:50","pubTimestamp":1791550200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261009:nTUA1ZLDRL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IHE","PBE","RPRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674328258","title":"Sino Biopharmaceutical Stock Falls 1.4% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2674328258","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674328258?lang=en_us&edition=fundamental","pubTime":"2026-10-09 16:33","pubTimestamp":1791534780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. slipped 1.4% to 5.41 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.8% to 24211.35.This was the stock's third consecutive day of losses.Sino Biopharmaceutical Ltd. closed 33% short of its 52-week high of HK$8.08, which the company reached Oct. 10.The stock demonstrated a mixed performance when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 2.2% and Amgen Inc. remained unchanged.Trading volume totaled 72.7 million shares, compared to the 50-day average of 80.1 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242646821.SGD","LU1983299246.USD","IE00B2B36J28.USD","LU1571399168.USD","IE00BFTCPJ56.SGD","LU1061106388.HKD","AMGN","LU0058720904.USD","IE00BJT1NW94.SGD","BK4139","BK1515","BK4599","HK0000165453.HKD","IE0009355771.USD","LU2468319806.SGD","PJP","BBH","IBBQ","BK4534","LU0320765992.SGD","BK4581","LU0868494617.USD","LU1057294990.SGD","LU0122379950.USD","01177","BK1191","BIB","IE00BZ08YR35.GBP","LU2242652126.USD","IE00BZ08YT58.USD","LU0109394709.USD","IE00B4R5TH58.HKD","LU0889565916.HKD","BK4533","IE00BJJMRZ35.SGD","BK4585","LU0289739699.SGD","BK4588","LU2112291526.USD","IE0002141913.USD","BK4566","LU2089984988.USD","IBB","BK1521","IE00BZ08YS42.EUR","LU1023059063.AUD","TBXU","SG9999001440.SGD","PBE","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674184887","title":"Linical Wins $20 Million U.S. Biotech Order as FDA Environment Normalizes","url":"https://stock-news.laohu8.com/highlight/detail?id=2674184887","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674184887?lang=en_us&edition=fundamental","pubTime":"2026-10-09 10:52","pubTimestamp":1791514334,"startTime":"0","endTime":"0","summary":"Linical Co., Ltd. ( ($JP:2183) ) has issued an update. Linical Co., Ltd. has secured a large new order from a U.S. biotechnology company worth 20.4...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/linical-wins-20-million-u-s-biotech-order-as-fda-environment-normalizes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/linical-wins-20-million-u-s-biotech-order-as-fda-environment-normalizes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","JDOC","RSPH","PBE","BK4581","BBP","BK4588","IEIH","DARP","LNGR","XT","FHLC","IBB","FWD","SYNB","XBIX","AGNG","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674488039","title":"Amgen (AMGN) In Focus As MariTide Buzz Tests Whether The Stock Is Fully Valued","url":"https://stock-news.laohu8.com/highlight/detail?id=2674488039","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674488039?lang=en_us&edition=fundamental","pubTime":"2026-10-09 10:36","pubTimestamp":1791513400,"startTime":"0","endTime":"0","summary":"Amgen (AMGN) is back in focus after fresh attention on its obesity drug candidate MariTide, now in late-stage Phase III testing, and new precision medicine partnerships that together are shaping sentiment toward the stock.\nThose headlines are landing on a stock that has already been rebuilding confidence. Amgen’s share price is up 12.12% over 90 days and 24.36% year to date, while its 1-year total shareholder return of 41.74% points to strong, dividend-backed momentum rather than a...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/24816-card/1789038959684","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/24816-card/1789038959684"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amgn/amgen/news/amgen-amgn-in-focus-as-maritide-buzz-tests-whether-the-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amgn/amgen/news/amgen-amgn-in-focus-as-maritide-buzz-tests-whether-the-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4566","IE00B2B36J28.USD","IE00B4R5TH58.HKD","BK4534","LU0889565916.HKD","LU2468319806.SGD","LU2112291526.USD","BBH","LU1571399168.USD","LU0320765992.SGD","IE00BFTCPJ56.SGD","AMGN","PBE","BK4585","LU1983299246.USD","SG9999001440.SGD","IBB","LU0289739699.SGD","IE00BJJMRZ35.SGD","IE0002141913.USD","IBBQ","TBXU","LU0868494617.USD","LU1057294990.SGD","LU2089984988.USD","LU0058720904.USD","LU0109394709.USD","LU0122379950.USD","BK4533","PJP","LU1061106388.HKD","LU2242646821.SGD","IE00BJT1NW94.SGD","BIB","BK4581","BK4599","BK4588","BK4139","LU1023059063.AUD","IE0009355771.USD","LU2242652126.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674886821","title":"Vertex to Raise Up to C$7 Million in Subordinated Loan with Attached Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2674886821","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674886821?lang=en_us&edition=fundamental","pubTime":"2026-10-09 07:38","pubTimestamp":1791502698,"startTime":"0","endTime":"0","summary":"An update from Vertex Resource Group Ltd. ( ($TSE:VTX) ) is now available. Vertex Resource Group Ltd., a North American environmental services firm...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-to-raise-up-to-c7-million-in-subordinated-loan-with-attached-warrants?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-to-raise-up-to-c7-million-in-subordinated-loan-with-attached-warrants?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBH","IE0002141913.USD","LU0823416689.USD","SGXZ57979304.SGD","IDNA","TBXU","LU0061475181.USD","BK4588","LU2362541513.USD","LU1035775433.USD","LU2462157665.USD","LU0256863811.USD","LU1778281490.HKD","VRTX","LU1093756168.USD","LU1674673428.USD","BK4532","PBE","IE00B19Z3B42.SGD","LU1430594728.SGD","BK4567","SG9999001176.USD","SG9999013999.USD","IE00B19Z9P08.USD","LU0417517546.SGD","LU0566484027.USD","BK4139","IE00B19Z3581.USD","LU1815336091.USD","IE00BJT1NW94.SGD","IBB","LU2089984988.USD","BIB","LU0058720904.USD","LU2456880835.USD","GNMX","IBBQ","VERX","LU2468319806.SGD","LU2362541273.HKD","LU2237438978.USD","IE0009355771.USD","BK4585","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU2417539215.USD","LU1559883803.SGD","IE00B894F039.SGD","LU0432979614.USD","LU0757428866.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674883067","title":"Press Release: Vertex Resource GROUP LTD. Announces Subordinated TERM LOAN of up to C$7,000,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2674883067","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674883067?lang=en_us&edition=fundamental","pubTime":"2026-10-09 06:30","pubTimestamp":1791498600,"startTime":"0","endTime":"0","summary":"SHERWOOD PARK, AB, Oct. 8, 2026 /CNW/ -- (TSXV: VTX) -- Vertex Resource Group Ltd. (\"Vertex\" or the \"Corporation\") announces its intention to enter into a subordinated credit arrangement with Factory ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBXU","LU1093756325.SGD","IE00BZ9MQY76.HKD","BBH","LU2456880835.USD","IBBQ","BK4585","91512","LU1674673691.USD","LU2468319806.SGD","LU0109394709.USD","IE00B4R5TH58.HKD","LU0061475181.USD","BK4139","GNMX","SG9999001176.USD","LU0757428866.USD","PBE","LU0079474960.USD","BK4588","IE0009355771.USD","SGXZ57979304.SGD","LU0889565916.HKD","LU2362541273.HKD","LU2362540622.SGD","LU1585245621.USD","BK4567","LU2237438978.USD","IE0002270589.USD","IE00BJT1NW94.SGD","LU0566484027.USD","BIB","LU0289739699.SGD","IBB","IE00B894F039.SGD","BK4533","LU2462157665.USD","VRTX","VERX","IDNA","LU2417539215.USD","LU0320765992.SGD","LU0432979614.USD","SG9999013999.USD","91013","LU1674673428.USD","IE00B19Z9Z06.USD","SG9999001176.SGD","LU1778281490.HKD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674988830","title":"Biogen Inc. Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2674988830","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674988830?lang=en_us&edition=fundamental","pubTime":"2026-10-09 04:55","pubTimestamp":1791492900,"startTime":"0","endTime":"0","summary":"DJ Biogen Inc. Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Biogen Inc.  slipped 1.67% to $218.43 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 0.10% to 51,231.64 and the S&P 500 Index  falling 0.47% to 7,765.36.This was the stock's third consecutive day of losses.Biogen Inc. closed 5.23% short of its 52-week high of $230.49, which the company achieved on September 28th.The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson  fell 0.76% to $256.48, Pfizer Inc.  fell 0.64% to $27.82, and AbbVie Inc.  rose 0.39% to $272.42.Trading volume  eclipsed its 50-day average volume of 951,054.Data source: Dow Jones Market Data, FactSet. Data compiled October 8, 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0109394709.USD","LU0320765992.SGD","BK4585","PBE","BK4139","IE00B19Z9P08.USD","BIIB","BK4532","BMED","IE00B894F039.SGD","LU0889565916.HKD","IE00B19Z9Z06.USD","BK4533","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674009023","title":"Amgen’s Monthly Diabetes Shot Takes Aim at Semaglutide in New Phase 3 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2674009023","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674009023?lang=en_us&edition=fundamental","pubTime":"2026-10-09 00:31","pubTimestamp":1791477115,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen lines up a head-to-head diabetes trial that could reshape the GLP-1 la...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgens-monthly-diabetes-shot-takes-aim-at-semaglutide-in-new-phase-3-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgens-monthly-diabetes-shot-takes-aim-at-semaglutide-in-new-phase-3-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBH","IE0002141913.USD","LU1057294990.SGD","LU0889565916.HKD","TBXU","BK4588","SG9999001440.SGD","LU1983299246.USD","LU0868494617.USD","PJP","PBE","BK4139","IE00BFTCPJ56.SGD","LU2112291526.USD","IE00BJT1NW94.SGD","BK4566","LU0122379950.USD","BK4533","LU1061106388.HKD","IBB","LU1023059063.AUD","LU2089984988.USD","BIB","AMGN","JDOC","BK4534","LU0058720904.USD","BK4581","LU0320765992.SGD","IBBQ","LU2242646821.SGD","LU2468319806.SGD","LU1571399168.USD","IE0009355771.USD","LU0289739699.SGD","BK4585","BK4599","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU0109394709.USD","IE00BJJMRZ35.SGD","LU2242652126.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673800513","title":"Dow's Nearly 150-Point Fall Led by Losses for Shares of Amgen, Johnson & Johnson","url":"https://stock-news.laohu8.com/highlight/detail?id=2673800513","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673800513?lang=en_us&edition=fundamental","pubTime":"2026-10-08 22:51","pubTimestamp":1791471060,"startTime":"0","endTime":"0","summary":"DJ Dow's Nearly 150-Point Fall Led By Losses For Shares Of Amgen, Johnson & JohnsonThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen and Johnson & Johnson are trading lower Thursday morning, dragging the Dow Jones Industrial Average into negative territory.The Dow  was most recently trading 142 points, or 0.3%, lower, as shares of Amgen  and Johnson & Johnson  have contributed to the index's intraday decline.Amgen's shares are off $10.59, or 2.6%, while those of Johnson & Johnson are down $5.85, or 2.3%, combining for a roughly 98-point drag on the Dow.Also contributing significantly to the decline are Merck , UnitedHealth , and Boeing .A $1 move in any of the benchmark's 30 components equates to a 5.94-point swing.Data source: Dow Jones Market Data, FactSet. Data compiled October 8, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2592432038.USD","LU0943347566.SGD","LU1057294990.SGD","BBH","IE00BSNM7G36.USD","LU0320765992.SGD","IE00B42XCP33.USD","LU0210536198.USD","LU0511384066.AUD","LU0545562505.USD","LU1032466523.USD","BK4599","LU1551013342.USD","LU2456880835.USD","LU0889565916.HKD","LU0689472784.USD","BMED","IE000BZT7R73.USD","BK4568","BK4592","LU1066051498.USD","BK4559","LU1989771016.USD","LU0553294199.USD","LU1506573853.SGD","LU0689626769.HKD","LU1496350502.SGD","LU1929549753.HKD","LU1228905540.USD","BK4564","LU0426412945.USD","MEDX","IE0002141913.USD","LU0426417589.USD","IE000M9KFDE8.USD","LU1003077747.HKD","LU0345770308.USD","LU0820562030.AUD","AMGN","BK4187","IE00B2B36J28.USD","JNJ","LU0203347892.USD","LU0472753341.HKD","LU1244550221.USD","LU2112291526.USD","LU1023059063.AUD","LU1043141396.HKD","LU0795875169.SGD","LU2471134879.HKD","DJIA","LU0162691827.USD","LU1059921491.USD","LU2242652126.USD","FTXH","LU2750360641.GBP","BK4533","LU0057025933.USD","LU1066051225.USD","LU2213496289.HKD","LU1585245621.USD",".DJI","LU1571399168.USD","BOEU","BK4139","BK4504","LU1032955483.USD","IE000MB6IJN5.SGD","LU1074936037.SGD","LU1674673691.USD","IE00BJJMRZ35.SGD","LU1066051811.HKD","LU0994945656.USD","BK4551","LU0124676726.USD","LU1196500208.SGD","LU2129689605.HKD","BK4007","LU2403377893.USD","IE0001KFT4U8.USD","LU0345769631.USD","IE00BLSP4239.USD","LU1280957306.USD","LU2347655156.SGD","SG9999001176.USD","SG9999002232.USD","LU0868494617.USD","LU2471134523.USD","BK4585","MGK","SG9999013999.USD","VHT","FDN","LU0820561909.HKD","LU1551013425.SGD","LU2430703178.SGD","LU1983299246.USD","LU2602419157.SGD","04332","LU0203345920.USD","IE0034235303.USD","IE00B19Z3B42.SGD","LU0820561818.USD","DIA","LU1429558221.USD","LU1430594728.SGD","GRNY","LU0545039389.USD","LU2023250330.USD","JDOC","LU2133065610.SGD","IE0009355771.USD","LU0640476718.USD","LU0234572021.USD","DGRW","IBB","LU0053666078.USD","LU2487616109.SGD","YMAX","SG9999001176.SGD","SDY","XLV","PPA","LU1674673428.USD","IE00BVYPNV92.GBP","IE00B4R5TH58.HKD","BK4588","IE00BFTCPJ56.SGD","BK4566","LU0072461881.USD","LU0289739699.SGD","LU1435385759.SGD","LU1221951129.SGD","FHLC","LU2468319806.SGD","LU0792757196.USD","VYM","LU2417539215.USD","LU2505996681.GBP","BK4534","PBE","SDOW","LU1629891620.HKD","LU0070217475.USD","LU0985320562.USD","DGRO","IE000F7OJYX1.SGD","LU1267930813.SGD","LU2756315318.SGD","NATO","IE00BDGV0183.EUR","BK4516","IE00BLSP4452.SGD","LU1778281490.HKD","LU0114720955.EUR","LU0289739343.SGD","LU0289961442.SGD","BIB","BOEG","IE00BGHQF631.EUR","LU0683600562.USD","LU0234570918.USD","LU1066053197.SGD","LU0738911758.USD","LU1162221912.USD","LU1718418525.SGD","FOWF","IE000SO60NU8.SGD","SCHD","IE000WAW04H5.SGD","LU2471134796.USD","LU0058720904.USD","LU2430703251.USD","LU1228905037.USD","LU1935042991.SGD","LU0345770993.USD","LU0912757837.SGD","LU1894683264.USD","LU2471134952.CNY","IDEF","IE00B3PB1722.GBP","PJP","LU1244550494.USD","IE00BZ1G4Q59.USD","IE00BBT3K403.USD","IE00B3T34201.USD","LU0882574055.USD","LU0320765646.SGD","LU1043141123.HKD","LU1061106388.HKD","LU1244550577.SGD","GDOC","LU0795875086.SGD","LU2089984988.USD","LU2505996509.AUD","LU2750360997.AUD","SG9999002224.SGD","IE0002270589.USD","TBXU","DVY","VUG","SCHG","LU0889566641.SGD","LU1145028129.USD","SGXZ80539844.SGD","LU2236285917.USD","LU1914381329.SGD","LU0432979614.USD","IE00BVYPNW00.USD","IE00B1BXHZ80.USD","IE00B7SZLL34.SGD","BOED","LU0787776722.HKD","LU1221951046.USD","TOPT","LU2756315664.SGD","LU1121112475.USD","LU0122379950.USD","LU2326559502.SGD","LU0466842654.USD","LU2896262040.SGD","VYMI","SGXZ57979304.SGD","MISL","BK4581","IYH","IE00BFXG1179.USD","DDM","LU1732800096.USD","SG9999001440.SGD","IE0000B7K699.USD","LU1291159041.SGD","RXL","LU1894683348.USD","BK4550","TRUH","DJX","UDOW","XLI","LU0949170772.SGD","LU2129689514.USD","BA","DOG","ITA","IBBQ","LU0345769128.USD","LU2129689431.USD","FDVV","IE00BKVL7J92.USD","IHE","LU0098860793.USD","LU2430703095.HKD","LU0661504455.SGD","MYMmain","IE00BJT1NW94.SGD","LU1732799900.SGD","IXJ","DXD","IE00BN8TJ469.HKD","LU0069063385.USD","LU1261432733.SGD","LU2242646821.SGD","BK4532","IE00B19Z3581.USD","LU0210528500.USD","LU0109394709.USD","LU0964807845.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673072511","title":"Amgen Stock Forecast: Pipeline Wins Strengthen Growth Story as MariTide Phase 3 Advances","url":"https://stock-news.laohu8.com/highlight/detail?id=2673072511","media":"TradingKey","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673072511?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:00","pubTimestamp":1791460800,"startTime":"0","endTime":"0","summary":"TradingKey - Amgen enters October with fresh Phase 3 pipeline wins, strong growth from Repatha and Imdelltra, and MariTide advancing across a broad obesity program.","market":"nz","thumbnail":"https://resource.tradingkey.com/uploads/20261008/AMGEN-7bfb3accd08d40ba905f9cb7227c2a13.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20261008/AMGEN-7bfb3accd08d40ba905f9cb7227c2a13.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/analysis/stocks/us-stocks/262205484-amgen-amgn-stock-forecast-october-8-2026-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B4R5TH58.HKD","SG9999001440.SGD","LU2112291526.USD","LU1571399168.USD","LU0889565916.HKD","BK4566","BBH","BK4139","BK4599","BK4534","LU0320765992.SGD","PBE","LU0058720904.USD","LU1061106388.HKD","IE00BJJMRZ35.SGD","LU1057294990.SGD","BK4581","IE0009355771.USD","AMGN","IE00B2B36J28.USD","LU2089984988.USD","BIB","IE00BJT1NW94.SGD","LU1983299246.USD","PJP","LU2242646821.SGD","IE0002141913.USD","LU0122379950.USD","BK4533","IBB","TBXU","IBBQ","LU2242652126.USD","BK4588","BK4585","LU0868494617.USD","LU0289739699.SGD","IE00BFTCPJ56.SGD","LU0109394709.USD","LU1023059063.AUD","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673907263","title":"Alnylam Pharmaceuticals (ALNY) Is Under Securities Fraud Investigation","url":"https://stock-news.laohu8.com/highlight/detail?id=2673907263","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673907263?lang=en_us&edition=fundamental","pubTime":"2026-10-08 19:30","pubTimestamp":1791459030,"startTime":"0","endTime":"0","summary":"Alnylam Pharmaceuticals (NasdaqGS:ALNY) faces an ongoing securities fraud investigation following a downward revision to its 2026 sales guidance.\nInvestigators are examining whether management disclosures around the updated full year 2026 outlook accurately reflected the business conditions at the time.\nThe probe focuses on potential gaps between prior public commentary on future sales expectations and the revised guidance now presented to investors.\nThe securities fraud investigation tied...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alny/alnylam-pharmaceuticals/news/alnylam-pharmaceuticals-alny-is-under-securities-fraud-inves","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alny/alnylam-pharmaceuticals/news/alnylam-pharmaceuticals-alny-is-under-securities-fraud-inves","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0889565916.HKD","ALNY","LU0882574055.USD","BK4548","BK4139","BK4588","LU0114720955.EUR","GNMX","PBE","LU0109394709.USD","BK4585","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673073709","title":"Biogen : RBC Cuts Target Price to $256 from $260","url":"https://stock-news.laohu8.com/highlight/detail?id=2673073709","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673073709?lang=en_us&edition=fundamental","pubTime":"2026-10-08 18:02","pubTimestamp":1791453763,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nFWN45U0XT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0320765992.SGD","LU0889565916.HKD","BK4585","BMED","LU0234570918.USD","BK4588","PBE","BK4533","BK4532","BK4139","IE00B19Z9Z06.USD","IE00B19Z9P08.USD","BIIB","IE00B894F039.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}